128
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

3D-QSAR and Molecular Docking Analysis for Natural Aurone Derivatives as Anti-Malarial Agents

ORCID Icon, &
Pages 6017-6032 | Received 19 Mar 2021, Accepted 09 Aug 2021, Published online: 02 Sep 2021
 

Abstract

Three-dimensional quantitative structure-activity relationships were studied on 35 natural aurone derivatives by the Topomer CoMFA method to establish the 3 D-QSAR models, and exerting potent affections as Qo site inhibitors in cytochrome b activity for anti-malaria. The cross-validated q2 value of the Topmer CoMFA model = 0.539, the non-cross-validated r2 = 0.793, rpred2 = 0.960, which revealed the model has good stability and predictability. The steric and electrostatic field visualization provided by the Topomer CoMFA model intuitively revealed the effects of different substituent structures. Using this information for molecule design, we theoretically obtained some new aurone derivatives as antimalarial drugs with higher activity. Furthermore, molecular docking was employed to explore the binding requirements between the ligands and the receptor protein. We obtained space relations by hydrogen bonds and hydrophobic interactions between aurone derivatives and the active site residues. The observations from these QSAR and molecular docking studies can be further used to design promising antimalarial drugs.

Disclosure statement

The authors declare that they have no conflict of interest.

Availability of data and material

All data generated or analyzed during this study are included in the article.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Funding

This work was supported by the National Natural Science Funds of China (21475081), the Natural Science Foundation of Shaanxi Province of China (2019JM-237), and the Graduate Innovation Fund of Shaanxi University of Science and Technology.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.